INSPIRE Pipeline™ Shield Post Approval Study (NCT05071963)
Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (16 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- Yale New Haven Hospital — New Haven, Connecticut
- Baptist Medical Center Jacksonville — Jacksonville, Florida
- Emory University Hospital — Atlanta, Georgia
- Endeavor Health - Evanston Hospital — Evanston, Illinois
- Norton Healthcare — Louisville, Kentucky
- Washington University in Saint Louis — St Louis, Missouri
- NYU Langone Medical Center — New York, New York
- Montefiore Medical Center — New York, New York
- The Cleveland Clinic Foundation — Cleveland, Ohio
- Oklahoma (OU) University Medical Center — Oklahoma City, Oklahoma
- Geisinger Medical Center — Danville, Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
- Prisma Health — Greenville, South Carolina
- Baylor Scott & White Research Institute — Dallas, Texas
- University of Utah Hospital — Salt Lake City, Utah
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Intracranial Aneurysm
- SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial — Arlington Heights, Illinois
- MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study — Hollywood, Florida
- Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation — Jacksonville, Florida
- Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial — Sherbrooke, Quebec
- NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study — Jacksonville, Florida
Explore by condition: All Intracranial Aneurysm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.